GTS Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
GTS Securities's GILD Position: Q3 2026 in Review
GTS Securities increased its Gilead Sciences (GILD) stake by 541% in Q3 2026, buying an estimated $3.5M and bringing the position to 29,535 shares worth $4.4M. The position accounts for 0.1% of the portfolio, ranked #150.
GTS Securities first reported a position in GILD in Q2 2023 and has held it in 14 quarters since. The position peaked at $8.51M in Q3 2023. 2,349 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- GTS Securities held 29,535 shares of Gilead Sciences worth $4.4M as of Q3 2026.
- GTS Securities bought 24,927 Gilead Sciences shares in Q3 2026, an estimated $3.5M.
- Gilead Sciences made up 0.1% of GTS Securities's portfolio in Q3 2026, its #150 holding.
- GTS Securities first reported a position in Gilead Sciences in Q2 2023 and has held it in 14 quarters since.
- GTS Securities's Gilead Sciences position peaked at $8.51M in Q3 2023.
- 2,349 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.